Latanoprost Zentiva (Latanoprost)

Latanoprost is a synthetic prostaglandin F2α analogue that binds to FP receptors in the ciliary body. This binding remodels the extracellular matrix of the uveoscleral outflow pathway, increasing aqueous humor drainage through that route and consequently lowering intraocular pressure.

The prescribed regimen is determined by the treating ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing are individualized based on the patient’s response and clinical judgment.

Safety data for Latanoprost in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by the prescriber.

To request Latanoprost Zentiva, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Latanoprost belongs to the prostaglandin analogue class, which generally offers once‑daily dosing and a strong intraocular pressure‑lowering effect. Compared with beta‑blockers such as timolol, prostaglandin analogues often have a more sustained pressure reduction and a different side‑effect profile, making them a first‑line choice for many patients.

Latanoprost eye drops should be stored at room temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from direct light and avoid freezing. Once opened, use the product within the period specified by the manufacturer, typically 30 days, and discard any remaining solution after that time.

The solution is applied topically to the conjunctival sac. The patient should wash their hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place a single drop into the eye. After instillation, close the eye gently and avoid blinking excessively for a few seconds.

Serious adverse events, although rare, include severe intraocular inflammation (uveitis), allergic reactions with swelling or rash around the eye, and corneal ulceration or keratitis that can threaten vision. Any sudden eye pain, vision loss, or marked redness should prompt immediate medical evaluation.

Latanoprost is contraindicated in patients with known hypersensitivity to the active ingredient or any component of the formulation. Caution is also advised for individuals with active ocular infections, severe inflammation, or a history of herpetic eye disease, as the medication may exacerbate these conditions.